Delivery Order SPE2DB22D2103-SPE2DB25FR9QG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,794.36 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of July 31, 2025. The contract was executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $26,227.70 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/milliliter pharmaceutical product on June 2, 2025, with a completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used in the treatment of inflammatory skin...
- The Defense Logistics Agency awarded a delivery order valued at $67,851.86 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen, a pharmaceutical product for federal medical procurement needs. This firm fixed-price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $17,574.35 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen vials under a firm fixed price contract type. This competitive award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $42,191.28 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen medication on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $94,011.78 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML PenML, a pharmaceutical product. This is a firm fixed price delivery order issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-competitive set-aside contract. The award will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and...
- The Defense Logistics Agency awarded a $50,801.12 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of SKYRIZI 150 mg/mL pen/mL, a pharmaceutical product used to treat inflammatory conditions. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 24, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $53,327.86 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen prefilled syringes. This firm fixed-price, competitively awarded contract was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order contract valued at $34,595.45 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injections on September 16, 2025. The contract utilizes a firm fixed price delivery order structure with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. This order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $61,540.45 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen, a pharmaceutical product. This non-competitive, firm fixed price delivery order was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line item delivery against AmerisourceBergen's existing federal...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9QGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $91,962.07 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen/ml pharmaceutical supplies. This firm fixed price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication primarily used in the treatment of inflammatory conditions, and this delivery order represents one of multiple pharmaceutical supply acquisitions AmerisourceBergen fulfills for the federal government. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $92.0k | 8/5/25 |